Saturday, July 11, 2026

pharma · Apnea of Prematurity · Safety and Pharmacokinetics

BELPHARMA

BELPHARMA drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Luxembourg, LU HQ
2011 Founded
16 Employees
EMA registrant Type
Company details
Status
Public
HQ
Luxembourg, LU
Founded
2011
Employees
16
Programs
3
Drugs
2
Patents
0
Intelligence · Drug Pipeline

BELPHARMA pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

BELPHARMA drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to BELPHARMA in public FDA and regional records.

  2. Development asset linked to BELPHARMA in public FDA and regional records.